KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Feb 26, 2016 $13.20 $13.20 $13.20 $13.20 350 900
Feb 25, 2016 $12.87 $12.87 $12.87 $12.87 388 100
Feb 24, 2016 $12.80 $12.80 $12.80 $12.80 1 016 900
Feb 23, 2016 $14.80 $14.80 $14.80 $14.80 364 800
Feb 22, 2016 $14.76 $14.76 $14.76 $14.76 158 000
Feb 19, 2016 $14.93 $14.93 $14.93 $14.93 149 800
Feb 18, 2016 $14.77 $14.77 $14.77 $14.77 216 600
Feb 17, 2016 $15.42 $15.42 $15.42 $15.42 314 800
Feb 16, 2016 $14.52 $14.52 $14.52 $14.52 436 100
Feb 12, 2016 $14.31 $14.31 $14.31 $14.31 236 700
Feb 11, 2016 $13.52 $13.52 $13.52 $13.52 204 000
Feb 10, 2016 $13.59 $13.59 $13.59 $13.59 355 600
Feb 09, 2016 $13.50 $13.50 $13.50 $13.50 329 400
Feb 08, 2016 $14.28 $14.28 $14.28 $14.28 329 600
Feb 05, 2016 $15.25 $15.25 $15.25 $15.25 390 900
Feb 04, 2016 $16.39 $16.39 $16.39 $16.39 330 300
Feb 03, 2016 $16.62 $16.62 $16.62 $16.62 480 000
Feb 02, 2016 $16.77 $16.77 $16.77 $16.77 324 100
Feb 01, 2016 $17.14 $17.14 $17.14 $17.14 427 900
Jan 29, 2016 $17.14 $17.14 $17.14 $17.14 710 000
Jan 28, 2016 $17.02 $17.02 $17.02 $17.02 507 900
Jan 27, 2016 $18.63 $18.63 $18.63 $18.63 481 800
Jan 26, 2016 $20.64 $20.64 $20.64 $20.64 304 000
Jan 25, 2016 $21.34 $21.34 $21.34 $21.34 286 500
Jan 22, 2016 $22.21 $22.21 $22.21 $22.21 336 100
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT